Clinical trials: Intra Uterine Growth Retardation

Children Born With Serious Intra-uterine Growth Retardation

Saizen in Intra-uterine Growth Retardation

• Completed
• Age: All ages
• Phase 3
• Injection or infusion
• Results posted

Study of safety of Saizen® in children born with serious intra-uterine growth retardation (IUGR) treated to final height. An open, phase III study involving 17 centers in France.

Trial name

NCT01400698

Testing

Saizen® A, Saizen® B, Observation only

Volunteers

91 people

Sponsor

Merck KGaA, Darmstadt, Germany